Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (81-90 of 337) with videos related to

Pageof 34
Sort By:
Cancers|October 14, 2023
The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular GroupsOlga Ciobanu-Caraus, Thomas Czech, Andreas Peyrl, et al.
Neuro-Oncology|May 9, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patientsChristin Schmidt, Nil A Schubert, Sebastian Brabetz, et al.
Acta Neuropathologica|April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypesAndrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
Oncotarget|December 21, 2011
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiationDannis G van Vuurden, Esther Hulleman, Olga L M Meijer, et al.
Cancer Cell|December 17, 2015
A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor SubtypesClaudio Giachino, Jean-Louis Boulay, Robert Ivanek, et al.
Cancer Research|March 14, 2019
<i>MYC</i> Drives Group 3 Medulloblastoma through Transformation of Sox2<sup>+</sup> Astrocyte Progenitor CellsRan Tao, Najiba Murad, Zhenhua Xu, et al.
Acta Neuropathologica Communications|August 6, 2024
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastomaFoteini Tsiami, Chiara Lago, Noemi Pozza, et al.
Neuro-Oncology|April 14, 2011
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaAlessandro Raso, Samantha Mascelli, Roberto Biassoni, et al.
Nature Reviews. Cancer|November 24, 2012
Medulloblastomics: the end of the beginningPaul A Northcott, David T W Jones, Marcel Kool, et al.
Oncoimmunology|February 6, 2018
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastomaJeroen F Vermeulen, Wim Van Hecke, Elisabeth J M Adriaansen, et al.
Pageof 34

Showing results (81-90 of 337) with videos related to

Sort By:
Pageof 34
Cancers|October 14, 2023
The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular GroupsOlga Ciobanu-Caraus, Thomas Czech, Andreas Peyrl, et al.
Neuro-Oncology|May 9, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patientsChristin Schmidt, Nil A Schubert, Sebastian Brabetz, et al.
Acta Neuropathologica|April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypesAndrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
Oncotarget|December 21, 2011
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiationDannis G van Vuurden, Esther Hulleman, Olga L M Meijer, et al.
Cancer Cell|December 17, 2015
A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor SubtypesClaudio Giachino, Jean-Louis Boulay, Robert Ivanek, et al.
Cancer Research|March 14, 2019
<i>MYC</i> Drives Group 3 Medulloblastoma through Transformation of Sox2<sup>+</sup> Astrocyte Progenitor CellsRan Tao, Najiba Murad, Zhenhua Xu, et al.
Acta Neuropathologica Communications|August 6, 2024
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastomaFoteini Tsiami, Chiara Lago, Noemi Pozza, et al.
Neuro-Oncology|April 14, 2011
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaAlessandro Raso, Samantha Mascelli, Roberto Biassoni, et al.
Nature Reviews. Cancer|November 24, 2012
Medulloblastomics: the end of the beginningPaul A Northcott, David T W Jones, Marcel Kool, et al.
Oncoimmunology|February 6, 2018
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastomaJeroen F Vermeulen, Wim Van Hecke, Elisabeth J M Adriaansen, et al.
Pageof 34